Literature DB >> 4387223

Carbenicillin: activity in vitro and absorption and excretion in normal young men.

C B Smith, M Finland.   

Abstract

Carbenicillin is a new semisynthetic penicillin which differs from other penicillins in showing moderate antibacterial activity against Pseudomonas. Its activity in vitro is enhanced at low pH. Serum binding is of low order and does not appreciably alter activity. Strains of Pseudomonas exposed to subinhibitory concentrations of carbenicillin rapidly develop resistance by a mechanism that does not depend upon destruction of the drug. In normal subjects, high levels of anti-Pseudomonas activity are readily obtained in the urine after intramuscular injection. Levels of carbenicillin adequate to inhibit many strains of Pseudomonas can be achieved in serum only with an intravenous administration of a large dose. Carbenicillin appears to exhibit the same low degree of toxicity as do other penicillins.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4387223      PMCID: PMC547754          DOI: 10.1128/am.16.11.1753-1760.1968

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  14 in total

1.  Antibacterial action of "broad-spectrum" penicillins, cephalosporins and other antibiotics against Gram-negative bacilli isolated from bacteremic patients.

Authors:  N H Steigbigel; C E McCall; C W Reed; M Finland
Journal:  Ann N Y Acad Sci       Date:  1967-09-27       Impact factor: 5.691

2.  Clinical and laboratory studies with carbenicillin. A new penicillin active against Pseudomonas pyocyanea.

Authors:  W Brumfitt; A Percival; D A Leigh
Journal:  Lancet       Date:  1967-06-17       Impact factor: 79.321

3.  In vitro activity of carbenicillin against gram-negative bacilli.

Authors:  G P Bodey; L M Terrell
Journal:  J Bacteriol       Date:  1968-05       Impact factor: 3.490

4.  Prophylaxis and therapy for Pseudomonas aeruginosa infection with carbenicillin and with gentamicin.

Authors:  R J Jones; E J Lowbury
Journal:  Br Med J       Date:  1967-07-08

5.  Bacteriological observations on carbenicillin in the control of Pseudomonas aeruginosa infection in burns.

Authors:  C E Van Rooyen; J F Ross; G W Bethune; A C MacDonald
Journal:  Can Med Assoc J       Date:  1967-11-11       Impact factor: 8.262

6.  Carbenicillin: a new semisynthetic penicillin active against Pseudomonas pyocyanea.

Authors:  E T Knudsen; G N Rolinson; R Sutherland
Journal:  Br Med J       Date:  1967-07-08

7.  Gentamicin and colistin in chronic purulent bronchial infections.

Authors:  A Pines; H Raafat; K Plucinski
Journal:  Br Med J       Date:  1967-05-27

8.  Round table: are new antibiotics needed?

Authors:  M Finland; W M Kirby; Y A Chabbert; E B Chain; H F Dowling; L P Garrod; C W Pettinga; A C Todd
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1965

9.  New semi-synthetic penicillin active against Pseudomonas pyocyanea.

Authors:  P Acred; D M Brown; E T Knudsen; G N Rolinson; R Sutherland
Journal:  Nature       Date:  1967-07-01       Impact factor: 49.962

10.  Epidemiologic studies on gram-negative bacilli in the hospital and community.

Authors:  D M Kessner; M H Lepper
Journal:  Am J Epidemiol       Date:  1967-01       Impact factor: 4.897

View more
  14 in total

1.  Antibiotic susceptibility testing of gram-negative nonfermentative bacilli.

Authors:  K A Ruddell; C R Anselmo
Journal:  Antimicrob Agents Chemother       Date:  1975-04       Impact factor: 5.191

2.  Turbidimetric bioassay for carbenicillin.

Authors:  J P Stankewich; R P Upton
Journal:  Antimicrob Agents Chemother       Date:  1973-03       Impact factor: 5.191

3.  Carbenicillin in the treatment of gonorrhea in males.

Authors:  M Nelson
Journal:  Health Serv Rep       Date:  1972-10

4.  Combined action of carbenicillin and gentamicin on Pseudomonas aeruginosa in vitro.

Authors:  M Sonne; E Jawetz
Journal:  Appl Microbiol       Date:  1969-06

5.  Bladder catheterization increases susceptibility to infection that can be prevented by prophylactic antibiotic treatment.

Authors:  Matthieu Rousseau; H M Sharon Goh; Sarah Holec; Matthew L Albert; Rohan Bh Williams; Molly A Ingersoll; Kimberly A Kline
Journal:  JCI Insight       Date:  2016-09-22

6.  Susceptibility of Pseudomonas aeruginosa to tobramycin or gentamicin alone and combined with carbenicillin.

Authors:  E L Anderson; P K Gramling; P R Vestal; W E Farrar
Journal:  Antimicrob Agents Chemother       Date:  1975-09       Impact factor: 5.191

7.  Tobramycin (nebramycin factor 6): in vitro activity against Pseudomonas aeruginosa.

Authors:  R D Meyer; L S Young; D Armstrong
Journal:  Appl Microbiol       Date:  1971-12

8.  Influence of serum and calcium on the bactericidal activity of gentamicin and carbenicillin on Pseudomonas aeruginosa.

Authors:  S D Davis; A Iannetta
Journal:  Appl Microbiol       Date:  1972-04

9.  In vitro susceptibility of Pseudomonas aeruginosa to carbenicillin and the combination of carbenicillin and gentamicin.

Authors:  J P Phair; C Watanakunakorn; T Bannister
Journal:  Appl Microbiol       Date:  1969-09

10.  Effect of carbenicillin on Pseudomonas aeruginosa.

Authors:  P Chadwick
Journal:  Can Med Assoc J       Date:  1969-10-04       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.